Cargando…

Recombinant adenoviral vaccine encoding the spike 1 subunit of the Middle East Respiratory Syndrome Coronavirus elicits strong humoral and cellular immune responses in mice

BACKGROUND AND AIM: Middle East respiratory syndrome coronavirus (MERS-CoV) has rapidly spread throughout the Middle East since its discovery in 2012. The virus poses a significant global public health threat with potentially devastating effects. In this study, a recombinant adenoviral-based vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ababneh, Mustafa, Alrwashdeh, Mu’men, Khalifeh, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Veterinary World 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868266/ https://www.ncbi.nlm.nih.gov/pubmed/31849416 http://dx.doi.org/10.14202/vetworld.2019.1554-1562

Ejemplares similares

Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients
por: Tomas-Grau, Rodrigo Hernán, et al.
Publicado: (2022)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats
por: Liu, Ran-Yi, et al.
Publicado: (2005)

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2
por: Ukey, Rahul, et al.
Publicado: (2021)

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2
por: Ukey, Rahul, et al.
Publicado: (2022)

Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
por: Shim, Byoung-Shik, et al.
Publicado: (2010)

Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
por: Prompetchara, Eakachai, et al.
Publicado: (2021)

Bone Fracture Patterns and Distributions according to Trauma Energy
por: Almigdad, Ahmad, et al.
Publicado: (2022)

A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector
por: WATANABE, MASAMI, et al.
Publicado: (2014)

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines
por: Van Coillie, Julie, et al.
Publicado: (2023)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Co-immunization with HIV Env DNA and protein elicit long-lasting strong cellular and humoral immune responses
por: Li, J, et al.
Publicado: (2012)

Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro
por: Gribova, I.Yu., et al.
Publicado: (2011)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023)

Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice
por: Maharjan, Puna Maya, et al.
Publicado: (2021)

Interleukin-Encoding Adenoviral Vectors as Genetic Adjuvant for Vaccination against Retroviral Infection
por: Ohs, Inga, et al.
Publicado: (2013)

Construction and characterization of an adenoviral vector encoding human bone morphogenetic protein-2
por: Peng, Liangquan, et al.
Publicado: (2020)

Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo
por: Hudacek, Andrew W, et al.
Publicado: (2014)

Seamless assembly of recombinant adenoviral genomes from high-copy plasmids
por: Miciak, Jessica J., et al.
Publicado: (2018)

Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral Antigenicity
por: Natsume, Atsushi, et al.
Publicado: (2000)

Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments
por: Zeng, Fanya, et al.
Publicado: (2004)

Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Specific NFκB subunit activation and kinetics of cytokine induction in adenoviral keratitis
por: Rajaiya, Jaya, et al.
Publicado: (2009)

Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
por: Alluhaybi, Khalid A., et al.
Publicado: (2021)

Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19
por: Richardson, Christopher D
Publicado: (2022)

Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice
por: Kirk, Natalie M., et al.
Publicado: (2023)

Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques
por: Lorin, Clarisse, et al.
Publicado: (2015)

Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice
por: Zheng, Yu, et al.
Publicado: (2020)

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge
por: Cox, Freek, et al.
Publicado: (2018)

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

Stability of a Recombinant Adenoviral Vector: Optimization of Conditions for Storage, Transport and Delivery
por: Ugai, Hideyo, et al.
Publicado: (2002)

Bacterial RecA Protein Promotes Adenoviral Recombination during In Vitro Infection
por: Lee, Jeong Yoon, et al.
Publicado: (2018)

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
por: Kim, Eun, et al.
Publicado: (2014)

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
por: Laczkó, Dorottya, et al.
Publicado: (2020)

Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives
por: Chen, Guang-xia, et al.
Publicado: (2014)

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01
por: Iyer, Arun V., et al.
Publicado: (2009)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p9c7opgb8fu693qj9gsscfnjcd